Hepatic hemangioma in celiac patients: data from a large consecutive series

Sara Massironi1, Federica Branchi2, Roberta Elisa Rossi2

  • 1Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milan, Italy.

Insights

Celiac disease patients show a significantly higher prevalence of hepatic hemangioma (HH). This finding suggests a potential link between autoimmune disorders and liver conditions, warranting further investigation into underlying mechanisms.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Autoimmune Diseases

Background:

  • Hepatic hemangioma (HH) prevalence varies, with unclear etiology.
  • Associations between HH and autoimmune disorders have been noted.
  • The relationship between celiac disease and HH requires further evaluation.

Purpose of the Study:

  • To determine the prevalence of hepatic hemangioma in patients with celiac disease.
  • To compare HH prevalence in celiac patients versus a non-celiac control group.
  • To investigate potential associations between celiac disease and HH.

Main Methods:

  • Liver ultrasound was performed on 97 consecutive celiac disease patients.
  • Findings were compared to 1352 non-celiac individuals without liver disease.
  • Statistical analysis was used to compare prevalence rates between groups.

Main Results:

  • Hepatic hemangioma was detected in 14.4% of celiac patients, significantly higher than controls (5.1%).
  • Among women, HH prevalence was 16.4% in celiac patients versus 5.9% in controls.
  • In celiac patients, HH typically presented as a single lesion (86%) with a median diameter of 1.3 cm.

Conclusions:

  • Celiac disease is associated with a significantly higher prevalence of hepatic hemangioma.
  • The mechanisms linking celiac disease and HH remain unclear.
  • Potential factors include autoimmune processes, metabolic changes, and gut-liver axis alterations.